A vast number of studies evaluated glypican-3 as a PET, ultrasound (US), NIR, and MR imaging target for HCC using several targeting moieties and conjugates of a different origin [40,41,42,43,44,142]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.